A full suite of services for the promotion of pharmaceutical products

in Uzbekistan

BREFFI TECH

We provide services to promote
the following types of products

Prescription brands
(RX-brands)

Non-prescription brands
(OTC-brands)

Medical equipment

Programme software for doctors and patients

If a product is not registered in Uzbekistan

we can assist with its registration

STEP 4

STEP 6

Key steps to launch and promote your brand in Uzbekistan

We analyze the market. After building an econometric model, we forecast sales volume and ROI, drawing on our expertise and experience which we have gained through the successful implementation of more than 300 projects.

Market sizing and econometric modelling

STEP 1

We conduct market research and shape the promotion strategy in accordance with brand specifics.

Developing the promotion strategy

STEP 2

We coordinate the process of registering a brand to allow its sale in the Uzbekistan market, and manage communication with the state regulator.

Registration of brand, if necessary

STEP 3

We have contracts in place with leading distributors and pharmacy chains throughout the Russian & CIS markets. We coordinate logistics from the manufacturer to pharmacy shelves/other retail outlets, and ensure that products remain stocked and available in appropriate volumes throughout the distribution channel.

To ensure effective communication we use promotional tools that are relevant to the target audience, including the resources of the biggest digital-contact centre in Europe. We also communicate directly with 700,000 CIS doctors.

We monitor the implementation of promotional campaigns from a quantitative, qualitative and business KPI perspective, and measure against our client’s the required ROI rate.

Setting up distribution channels and contracting with distributors and pharmacy chains

Execution of brand promotional plans with conventional and digital-tools

STEP 5

Analysis of promotional campaign results: campaign analysis and optimization

We do not only rely on our experience,
we trust the numbers

Before the start we evaluate:

We evaluate the feasibility and best approach for the promotion of a brand with statistical models

Market volume

Feedback from target audiences
on how best to position and
communicate the product

Competitive environment

Potential for synergies with existing projects and brands we are already promoting

Feedback from leading medical specialists on the product

Experience in promoting
similar brands

We know how to sucessfully promote brands
in the Russian & CIS markets

10 years of successful pharmaceutical brand promotion

In 2021 we promoted more than 100 RX-brands and 100 OTC-brands

Our team consists of 200 highly experienced staff who have worked for the world’s leading pharmaceutical companies

Comprehensive brand promotion on the Russian & CIS markets

The biggest digital contact center in Europe

The biggest team in CIS for the
digital-promotion of pharmaceutical brands

We carry out projects with 700,000 doctors throughout Russia & CIS

Contracts with 197 opinion leaders in Russia & CIS

More than 150 medical representatives communicate with healthcare specialists each day

WHICH tools are used for communicatiON with healthcare professionals?

F2F visits

Calls

Emails

Conferences and
conventions

Messengers

Media advertisement

Remote visits

Webinars

Offline and online events

Also in our team

20 marketing specialists with high level medical education

Contracts with 197 key opinion leaders in Russia and abroad

150 medical representatives responsible for communication with doctors

More than 30 scientific communities participating in projects

Your brand is looked after by BREFFI’s team of experts.
They are medically educated and have extensive experience working in, and for, the world’s leading pharmaceutical companies

Our team consists of 200 staff members

We fully adhere to all legal, ethical and compliance
requirements for the promition of pharmaceutical brands

Examples of several projects promoting pharmaceutical brands in CIS

Brands: INN Colecalciferolum, INN Clindamycinum

Target audience: gynecologists

Results:
INN Colecalciferolum: +21% increase in sales volume in 2019 vs 2018
INN Clindamycinum: +12% increase in sales volume in 2019 vs 2018

Brand: INN Levocitirizinum

Target audience: allergists, dermatologists, otolaryngologists, pediatricians

Results:
+15% increase in sales in 2019 vs 2018
+2% increase in sales volume in 2019 vs 2018

Brand: NDA

Target audience: ophtalmologists

Results:
+9% increase in sales in 2020 vs 2019
+4% increase in sales volume in 2020 vs 2019

Case 1

Case 2

Case 3

We use our own products and services to promote pharmaceutical brands in Uzbekistan

Predictive system for assessing and managing the effectiveness of marketing tools

unique author's content
to promote your brands

Econometric models

Smart Content

System for omni-channel communication with healthcare professionals supported by business process management platforms

Database of healthcare professionals, CRM system, syndication studies, CLM system, Patient Support Programs (Patient Support Programs)

Omni-channel marketing

IT-services

The data in this form is intended for confidential and, if desired, anonymous questions and reports regarding potential violations of anti-corruption policies, personal data handling rules, and other Company requirements.
Retaliation or pressure against individuals who report violations in good faith is strictly prohibited.

Reports can also be sent to the Company’s official email addresses:
– For matters of business ethics, conflicts of interest, and anti-corruption requirements: compliance@breffi.uz
– For matters of personal data processing and protection: privacy@breffi.uz